Friday, May 1, 2026

LG Uplus Unveils Cutting-Edge IoT Solutions at WATER KOREA 2026: Revolutionizing Water Management

LG Uplus will showcase its IoT solutions for water management at the International Water Industry Expo, enhancing efficiency and safety.

Top College Golfer Michael Thorbjornsen Chooses LIV Golf Over Masters Debut

NCAA champion Michael Thorbjornsen joins LIV Golf, forgoing his Masters invite to learn from top players and compete globally.

South Korea and Japan’s Top Leaders Converge: What’s at Stake in Yoon-Kishida Summit?

South Korean President Yoon Suk Yeol and Japanese Prime Minister Kishida Fumio have commenced their summit meeting in South Korea.

Tag: botulinum toxin

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Hugel holds ‘Letybo’ training in Indonesia to boost competitiveness and brand awareness

Hugel expands in Indonesia with a training program for Letybo, enhancing local medical professionals' skills and brand loyalty.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

INIBO Launch: How This New Botulinum Toxin is Transforming the Aesthetic Market in Peru

Inibio launched its botulinum toxin product Inibo in Peru, marking a significant entry into the Latin American medical aesthetics market.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Botox Faces New Challenger: Chong Kun Dang’s Toxin Shows Non-Inferiority in China Study

Chong Kun Dang's CKDB-501A shows non-inferiority to Botox in Phase 3 trials for treating glabellar lines, with promising safety data.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.